Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol
Bernacer, M.; Aracil, J.; Contra, T.; Gil, C.; López, J.; López-Ibor, B.; Martín, N.; Melero, C.; Valverde, F.; Vecilla, C.
Anales Espanoles de Pediatria 29(Suppl 34): 68-72
1988
ISSN/ISBN: 0302-4342 PMID: 3214042 Document Number: 312549
Document emailed within 1 workday
Related Documents
Pavlovsky, S. 1981: Argentinian Group for the Treatment of Acute Leukemia: our experience in the treatment of acute lymphoblastic leukemias Sangre 26(5b): 845-854de Diego-Floreschapa, J.; López-Hernández, M.; Borbolla-Escoboza, J.R.; Trueba-Christy, E.; Carrillo-Rosales, T.; González-Avante, M. 1999: Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center Gaceta Medica de Mexico 135(3): 253-258
Popa, A.V.; Maiakova, S.A.; Kurmashov, V.I. 1997: Therapeutic results in children with acute non-lymphoblastic leukemia treated with modified BFM-87 protocol Voprosy Onkologii 43(4): 414-417
López-Hernández, M.A.; de Diego Flores-Chapa, J.; Borbolla-Escoboza, J.R.; Trueba-Christy, E.; Carrillo-Rosales, T.; González-Avante, M. 1998: Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center Gaceta Medica de Mexico 134(2): 145-151
Ortega, J.J.; Javier, G.; Olivé, T.; Montagut, J.M. 1988: 21 years in the treatment of acute lymphoblastic leukemias in children (1967-1987) Sangre 33(5): 372-382
Mathé, G.; Hayat, M.; Amiel, J.L.; Schwarzenberg, L.; Schneider, M.; Pouillart, P.; Cattan, A. 1971: Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man Bollettino dell'Istituto Sieroterapico Milanese 50(4): 251-259
Bancillon, A. 1991: Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol Archives Francaises de Pediatrie 48(8): 593-594
López-Hernández, M.A.; Alvarado-Ibarra, M.; Jiménez-Alvarado, R.M.ía.; De Diego-Flores, J.é E.; González-Avante, C.M. 2008: Adolescents with de novo acute lymphoblastic leukemia: efficacy and safety of a pediatric vs adult treatment protocol Gaceta Medica de Mexico 144(6): 485-489
Jessen, P.; Nielsen, B.; Jensen, I.M.; Ellegaard, J.; Hokland, P. 1992: Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation Ugeskrift for Laeger 154(52): 3754-3757
Invernizzi, R.; Rosanda, C.; Basso, G.; Conter, V.; di Cataldo, A.; Fenu, S.; Forni, M.; Frappampina, V.; Granchi, D.; Locatelli, F. 1992: Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias" Haematologica 77(1): 30-34
Vivanco Martínez, J.L.; López Pérez, J.; Melero Moreno, C.; Torres Valdivieso, M.J.; Palacios López, M.E.; Contra Gómez, T.; Martín Ramos, N.; Bernacer Borja, M.; Gil López, C.; Valverde Moreno, F. 1998: The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid) Anales Espanoles de Pediatria 49(6): 603-608
Tubiana, N.; Derre, M.; Carcassonne, Y. 1980: Immunological classification of acute lymphoblastic leukemias La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 56(47-68): 1993-1997
Cáp, J.; Babusíková, O.; Misíková, Z.; Foltinová, A. 1981: Use of immunological methods in characterizing acute lymphoblastic leukemias in childhood Bratislavske Lekarske Listy 76(2): 183-191
Löchner, K.; Siegler, G.; Führer, M.; Greil, J.; Beck, J.D.; Fey, G.H.; Marschalek, R. 1996: A specific deletion in the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias Cancer Research 56(9): 2171-2177
Thöne, I.; Kabisch, H.; Müller, J.; Winkler, K.; Landbeck, G. 1982: Immunological classification of acute lymphoblastic leukemias (ALL) in childhood. Origin and clinical significance of phenotypic variability Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 130(12): 883-890
Delia, D.; Polli, N.; Borrello, M.G.; Fontanella, E.; Biassoni, D.; Morandi, F.; Cattoretti, G.; Orazi, A.; Della Porta, G.D. 1988: Mixed-lineage leukemias and phenotypic shifts occurring in relapsed cases of acute T lymphoblastic lymphomas Leukemia 2(12 Suppl): 192s-197s
Eguchi-Ishimae, M.; Eguchi, M.; Ishii, E.; Knight, D.; Sadakane, Y.; Isoyama, K.; Yabe, H.; Mizutani, S.; Greaves, M. 2005: The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan Haematologica 90(11): 1511-1515
Linker, C.A. 1997: Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL) Leukemia 11(Suppl): S24-S27
Ribera, J.M.; Grañena, A.; Rozman, C.; Urbano-Ispizua, A.; Bladé, J.; Carreras, E.; Cervantes, F.; Marín, P.; Sierra, J.; Nomdedeu, B. 1990: Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol Sangre 35(1): 26-32
Sallan, S.E.; Clavell, L.A. 1984: Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience Seminars in Oncology 11(4 Suppl 3: 19-21